Droxidopa

Droxidopa, chemically (−)-L-threo-3,4-dihydroxyphenylserine, serves as a prodrug of norepinephrine, structurally akin to dopamine. Upon ingestion, it undergoes conversion into norepinephrine, predominantly in peripheral tissues. Widely applied in the treatment of neurogenic orthostatic hypotension (NOH), particularly associated with conditions like Parkinsons disease, multiple system atrophy, or pure autonomic failure, droxidopa addresses the hallmark symptom of blood pressure decline upon standing. By augmenting norepinephrine levels, it enhances blood pressure regulation, alleviating symptoms such as dizziness and lightheadedness, thus significantly contributing to improved patient well-being in the realm of autonomic nervous system dysfunction. Buy high quality Droxidopa from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Droxidopa